Minhao Yu
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
Papers in
-
- Ubiquitin and proteasome pathways 4
- RNA modifications and cancer 3
-
- Cancer-related molecular mechanisms research 5
- MicroRNA in disease regulation 3
- Co-authors
- Yang Luo (17 shared papers)Ming Zhong (16 shared papers)Shao‐Lan Qin (15 shared papers)Yifei Mu (10 shared papers)Jun Qin (7 shared papers)Yizhou Huang (4 shared papers)Ming Zhong (8 shared papers)Jianjun Chen (3 shared papers)
- Journals
- Biomedicine & Pharmacotherapy (3 papers)Cancer Letters (2 papers)Surgical Innovation (2 papers)Cancer Management and Research (2 papers)Cellular Immunology (1 paper)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Minhao Yu
37 papers receiving 819 citations
Peers
Comparison fields: 5 of 71
- Cancer Research 254
- Oncology 197
- Molecular Biology 396
- Immunology 90
- Geriatrics and Gerontology 14
Countries citing papers authored by Minhao Yu
This map shows the geographic impact of Minhao Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minhao Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minhao Yu more than expected).
Fields of papers citing papers by Minhao Yu
This network shows the impact of papers produced by Minhao Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minhao Yu. The network helps show where Minhao Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Minhao Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 116 | |
| 2 | 2016 | 72 | |
| 3 | 2023 | 53 | |
| 4 | 2020 | 48 | |
| 5 | 2018 | 45 | |
| 6 | 2021 | 39 | |
| 7 | 2019 | 35 | |
| 8 | Up-regulated CKS2 promotes tumor progression and predicts a poor prognosis in human colorectal cancer. | 2015 | 35 |
| 9 | 2016 | 34 | |
| 10 | 2016 | 31 | |
| 11 | 2015 | 30 | |
| 12 | 2023 | 27 | |
| 13 | 2020 | 27 | |
| 14 | 2016 | 25 | |
| 15 | 2018 | 23 | |
| 16 | 2021 | 21 | |
| 17 | 2022 | 16 | |
| 18 | 2019 | 16 | |
| 19 | 2022 | 14 | |
| 20 | Increased expression of Rab5A predicts metastasis and poor prognosis in colorectal cancer patients. | 2015 | 12 |
About Minhao Yu
Minhao Yu is a scholar working on Molecular Biology, Cancer Research, Oncology, Epidemiology and Cell Biology, having authored 39 papers that have together received 823 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (5 papers), Ubiquitin and proteasome pathways (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Cancer, Stress, Anesthesia, and Immune Response (4 papers), Hippo pathway signaling and YAP/TAZ (3 papers), MicroRNA in disease regulation (3 papers), Autophagy in Disease and Therapy (3 papers) and RNA modifications and cancer (3 papers). The work is most often cited by research in Cancer Research (254 citations), Oncology (197 citations), Molecular Biology (396 citations), Immunology (90 citations) and Geriatrics and Gerontology (14 citations). Minhao Yu has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Yang Luo, Ming Zhong, Shao‐Lan Qin, Yifei Mu, Jun Qin, Yizhou Huang, Ming Zhong, Jianjun Chen, Qiang Lv and Qi Yang. Their work appears in journals such as Biomedicine & Pharmacotherapy, Cancer Letters, Surgical Innovation, Cancer Management and Research and Cellular Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.